Your browser does not support JavaScript! ALCORTIN (1% IODOQUINOL - 2% HYDROCORTISONE) GEL [PRIMUS PHARMACEUTICALS]
DailyMed Logo Header image

Daily Med

Current Medication Information

Options

RxNorm Names

ALCORTIN (1% iodoquinol - 2% hydrocortisone) gel
[Primus Pharmaceuticals]


Category DEA Schedule Marketing Status
HUMAN PRESCRIPTION DRUG LABEL unapproved drug other
NOTE:THIS DRUG HAS NOT BEEN FOUND BY FDA TO BE SAFE AND EFFECTIVE, AND THIS LABELING HAS NOT BEEN APPROVED BY FDA. For further information about unapproved drugs, click here.
Drug Label Sections

Alcortin 2.0 g ucarton.jpg

NDC 68040-702-13 Rx only
Alcortin
Anti-fungal
Anti-bacterial
Anti-inflammatory
1% Iodoquinol 2% Hydrocortisone
See product literature for complete information.
TO OPEN A SINGLE PACK: Tear at notch along dotted line on front of package.
DOSAGE: Apply to affected area 3-4 times daily or as directed by your physician.
CONTENTS: This carton contains 24 single packs of 2.0 grams each of Alcortin gel. Each gram of
Alcortin contains 2.0% (20 mg) Hydrocortisone and 1.0% (10 mg) lodoquinol. Also contains 1.0%
(10 mg) Aloe polysaccharide and 5.0% (50 mg) Biopeptide combination of Palmitoyl oligopeptide,
Polyglyceryl methacrylate and Propylene glycol. Other ingredients: Aminomethyl propanol, Benzyl
alcohol, Blue 1, Carbomer, Fragrance, Glycerin, Magnesium aluminum silicate, PPG-20 methyl
glucose ether, Propylene glycol, Purified water, SO alcohol 40-B and Yellow 10.
WARNING: Keep out of reach of children. Not for use on infants or under diapers or occlusive
dressings. For external use only. Avoid contact with eyes. May discolor skin, hair or fabrics.
www.alcortin.com
U.S. Patents #6,436,679; #6,271 ,214;
#6,133,440; #5,708,038; patent pending
2004 Primus Pharmaceuticals, Inc. All rights reserved.
Distributed by:
Primus Pharmaceuticals, Inc.
Scottsdale, AZ 85254
www.primusrx.com
Manufactured by:
Harmony Labs, Inc.
Landis, NC 28088
NDC 68040-702-13
Rx only
Alcortin
1% iodoquinol - 2% hydrocrtisone
Anti-fungal
Anti-bacterial
Anti-inflammatory
24 PACK
Allergy tested
Paraben free
Contains moisturizers
For dermatological use only
Each pack contains
multiple doses
(depending on the surface area treated)
NetWt 48.0g(1.69 oz)
24 packs of 2.0g(0.07 oz) each
NDC 68040-702-13
Alcortin
1% iodoquinol - 2% hydrocrtisone
Rx only
Anti-fungal
Anti-bacterial
Anti-inflammatory
NDC 68040-702-13
Rx only
Alcortin
1% iodoquinol - 2% hydrocrtisone
Anti-fungal
Anti-bacterial
Anti-inflammatory
Paraben free
Contains moisturizers
For dermatological use only
Each pack contains
multiple doses
NetWt 48.0g(1.69 oz)
24 packs of 2.0g(0.07 oz) each
multiple doses
(depending on the surface area treated)
U Caton

Alcortin 2 g packet.jpg

NDC 68040-702-02 Rx only
Alcortin gel 1% iodoquinol - 2% hydrocortisone with Aloe
Allergy tested - Paraben free
Contains moisturizers
For dermatological use only
Each pack contains multiple doses(depending upon the surface area treated)
NetWt. 2.0 g (0.07oz)
See product literature for complete information.
Dosage: Apply to affect area 3-4 times daily or as directed by your physician.
To Open: Tear at notch along dotted line on front of package.
Contents: Each gram of Alcortin contains 2.0% (20 mg Hydrocortisone and 1.0% (10 mg) Iodoquinol.
Also contains 1.0% (10 mg) Aloe polysaccharide and 5.0% (50 mg) Biopeptide combination of Palmitoyl oligopeptide, Poyglyceryl methacrylate and Propylene glycol. Other ingredients: Aminomethyl propanol, Benzyl alcohol, Blue 1, Carbomer, Fragrance, Glycerin, Magnesium aluminum silicate, PPG-20 methyl glucose ether, Propylene glycol, Purified water, SD alcohol 40-B and Yellow 10.
Warning: Keep out of reach of children. Not for use on infants or under diapers or occlusive dressings. For external use only. Avoid contact with eyes. May discolor skin, hair or fabrics.
www.alcortin.com
Distributed by: Primus Pharmaceuticals, Inc.
Scottsdale, AZ 85254
Manufactured by: Harmony Labs, Inc.
Landis, NC 28088
U.S. Patents #6,436,679; #6,271,214; #6,133,440; #5,708,038; patent pending
Packet

Insert

Prescribing Information
ALCORTINgel
DESCRIPTION
Each gram of Alcortin contains 2.0% (20 mg)
Hydrocortisone and 1.0% (10 mg) lodoquinol.
Also contains 1.0% (10 mg) Aloe polysaccharide
and 5.0% (50 mg) Biopeptide combination
of Palmitoyloligopeptide, Polyglycerylmethacrylate
and Propylene glycol. Other
ingredients: Aminomethyl propanol, Benzyl
alcohol, Blue 1, Carbomer, Fragrance, Glycerin,
Magnesium aluminum silicate, PPG-20 methyl
glucose ether, Propylene glycol, Purified water,
SO alcohol 40-B and Yellow 10.
lodoquinol
lodoquinol is an antifungal and antibacterial
agent. Chemically, lodoquinol is [5,7-diiodo-8-
quinolinol] with the molecular formula
(C9HsI2NO)
Hydrocortisone
Hydrocortisone is an anti-inflammatory and
antipruritic agent. Chemically, hydrocortisone is
[Pregn-4-ene-3, 20-dione, 11, 17, 21- trihydroxy-,
(11 B)-] with the molecular formula
(C21H300s)
CLINICAL PHARMACOLOGY
Hydrocortisone has anti-inflammatory, antipruritic
and vasoconstrictive properties. While the
mechanism of anti-inflammatory activity is
unclear, there is evidence to suggest that a recognizable
correlation exists between vasoconstrictor
potency and therapeutic efficacy in
humans. lodoquinol has both antifungal and
antibacterial properties.
Pharmacokinetics
The extent of percutaneous absorption of topical
steroids is determined by many factors
including the vehicle, the integrity of the epidermal
barrier and the use of occlusive dressings.
Hydrocortisone can be absorbed from normal
intact skin. Inflammation and/or other inflammatory
disease processes in the skin increase
percutaneous absorption. Occlusive dressings
substantially increase the percutaneous
absorption of topical corticosteroids. Once
absorbed throuah the skin. hvdrocortisone is
tetrahydrocortisone and tetrahydrocortisol.
These are excreted in the urine, mainly conjugated
as glucuronides, together with a very
small proportion of unchanged hydrocortisone.
There are no data available regarding the percutaneous
absorption of iodoquinol; however,
following oral administration, 3-5% of the dose
was recovered in the urine as a glucuronide.
INDICATIONS AND USAGE
Based on a review of a related drug by the
National Research Council and subsequent
FDA classification for that drug, the indications
are as follows: "Possibly" Effective: Contact or
atopiC dermatitis; impetiginized eczema; nummular
eczema; endogenous chronic infectious
dermatitis; stasis dermatitis; pyoderma; nuchal
eczema and chronic eczematoid otitis externa;
acne urticata; localized or disseminated neurodermatitis;
lichen simplex chronicus; anogenital
pruritus (vulvae, scroti, ani); folliculitis; bacterial
dermatoses; mycotic dermatoses such as tinea
(capitis, cruris, corporis, pedis); monliasis; intertrigo.
Final classification of the less-than-effective
indications requires further investigation.
CONTRAINDICATIONS
Alcortin is contraindicated in those patients with
a history of hypersensitivity to hydrocortisone,
iodoquinol, aloe vera, glycine, histidine, lysine,
palmitic acid or any other components of the
preparation.
WARNINGS AND PRECAUTIONS
For external use only. Keep away from eyes. If
irritation develops, the use of Alcortin should be
discontinued and appropriate therapy instituted.
Staining of the skin, hair and fabrics may occur.
Not intended for use on infants or under diapers
or occlusive dressings. If extensive areas are
treated or if the occlusive dressing technique is
used, the possibility exists of increased systemic
absorption of the corticosteroid, and suitable
precautions should be taken. Children may
absorb proportionally larger amounts of topical
corticosteroids and thus be more susceptible to
systemic toxicity. Parents of pediatric patients
should be advised not to use tight-fitting diapers
or plastic pants on a child being treated in the
diaper area, as these garments may constitute
occlusive dressings. lodoquinol may be
absorbed through the skin and interfere with
thyroid function tests. If such tests are contemplated,
wait at least one month after discontinuance
of therapy to perform these tests. The ferric
chloride test for phenylketonuria (PKU) can
yield a false positive res!Jlt if iodoquinol is present
in the diaper or urine. Prolonged use may
result in overgrowth of non-susceptible organisms
requiring appropriate therapy. Keep out of
reach of children. Burning, itching, irritation and
dryness have been reported infrequently following
the use of topical corticosteroids.
Carcinogenesis, Mutagenisis and Impairment of
Fertility
: Long term animal studies have not
been performed to evaluate the carcinogenic
potential of the effect on fertility of hydrocortinegative
results. Mutagenicity studies have not
been performed with iodoquinol.
Pregnancy Category C: Animal reproductive
studies have not been conducted with Alcortin.
It is not known whether Alcortin can cause fetal
harm when administered to pregnant women or
can affect reproductive capacity. Alcortin
should be given to pregnant women only if
clearly needed.
Nursing Mothers: It is not known whether this
drug is excreted in human milk. Because many
drugs are excreted in human milk, caution
should be exercised when Alcortin is administered
to a nursing woman.
Pediatric Use: Safety and effectiveness in pediatric
patients under the age of 12 have not been
established.
ADVERSE REACTIONS
The following local adverse reactions are
reported infrequently with topical corticosteroids.
These reactions are listed in an approximate
decreasing order of occurrence. Burning,
itching, irritation, dryness, folliculitis, hypertrichosis,
acneiform eruptions, hypopigmentation,
perioral dermatitis, allergic contact dermatitis,
maceration of the skin, secondary infections,
skin atrophy, striae and miliaria.
DOSAGE AND ADMINISTRATION
Apply to affected area 3-4 times daily in accordance
with physician's directions or as directed
otherwise by a physician.
HOW SUPPLIED
FORM NDC # 68040-702-13 .
48.0 gram carton of 24-count of 2.0 gram gel individual packs
FORM NDC # 68040-702-02
2.0 gram gel individual pack
FORM NDC # 68040-702-08
10 count carton of 2.0 gram gel sample packs - not for resale
Each 2.0 gram gel pack contains multiple doses
depending on the surface area treated.
STORAGE
Store at room temperature 15°-30°C (59°-86°F).
Keep tightly closed.
Rx only www.alcortin.com
U.S. Patents
#6,436,679; #6,271 ,214; #6,133,440;
#5,708,038; patent pending
Manufactured for:
Primus Pharmaceuticals, Inc.
Scottsdale, AZ 85254
www.primusrx.com

ALCORTIN 
1% iodoquinol - 2% hydrocortisone gel
Product Information
Product TypeHUMAN PRESCRIPTION DRUG LABELItem Code (Source)NDC:68040-702
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Hydrocortisone (Hydrocortisone) Hydrocortisone2 g  in 100 g
IODOQUINOL (IODOQUINOL) IODOQUINOL1 g  in 100 g
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68040-702-0864 in 1 BOX
110 in 1 CARTON
1NDC:68040-702-022 g in 1 PACKET
2NDC:68040-702-1312 in 1 BOX
224 in 1 CARTON
22 g in 1 PACKET
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other07/25/2003
Labeler - Primus Pharmaceuticals (130834745)
Registrant - Harmony Labs, Inc. (105803274)
Establishment
NameAddressID/FEIBusiness Operations
Harmony Labs, Inc.105803274manufacture, label, pack, repack, relabel

Revised: 4/2010
 
Primus Pharmaceuticals

Visit The National Library of Medicine Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services